Daxor raises ~$8.1M in registered direct offering of 765,958 shares at $11.75/share

DAXOR CORP

Sold 765,958 shares at $11.75 per share for net proceeds of approx. $8,142,006 after fees.
Offering closed January 26, 2026; Lake Street Capital Markets acted as placement agent.
Shares registered under shelf registration statement on Form N-2 (File No. 333-281622) effective Jan 20, 2026.
Company did not specify use of proceeds; typical for working capital and general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DAXOR CORP entered into securities purchase agreement with certain investors valued at $11.75 per share (effective 2026-01-23).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: $11.75 per share
Effective: 2026-01-23

Exact text from the filing

On January 23, 2026, Daxor Corporation (“we” or “us”) entered into a definitive securities purchase agreement with certain investors pursuant to which we issued and sold an aggregate of 765,958 registered shares of our common stock at $11.75 per share

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DAXOR CORP entered into placement agency agreement with Lake Street Capital Markets, LLC (effective 2026-01-23).

Action: entry
Agreement: underwriting
Counterparty: Lake Street Capital Markets, LLC
Effective: 2026-01-23

Exact text from the filing

lacement agency agreement with Lake Street. A copy of the form of securities purchase agreement and the placement agency agreement are filed herewith as Exhibits 10.1 and 10.2, respectively,

View on SEC.gov

Browse all material agreements →

DAXOR CORP filing history →

Source: SEC EDGAR

accession 0001493152-26-003615

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.